SB 494 – Rhode Island

Status: Inactive / Dead
Year Introduced: 2021
Link: http://webserver.rilin.state.ri.us/BillText/BillText21/SenateText21/S0494A.pdf

AN ACT RELATING TO INSURANCE: Requires drug companies disclose to office of the health insurance commissioner acquisition costs of drugs approved by FDA, if acquisition cost is at least $100 for 30 day supply and requires disclosure of rebates, price protection payments.

Return to Database Search

© 2018- The SLIHCQ DatabaseInitial funding for this project was provided by the Robert Wood Johnson Foundation. The views expressed here do not necessarily reflect the views of the Foundation.

Associated Litigation:

No items found